Edition:
India

Lupin Ltd (LUPN.NS)

LUPN.NS on National Stock Exchange of India

919.35INR
17 Jan 2018
Change (% chg)

-- (--)
Prev Close
Rs919.35
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,094,575
52-wk High
Rs1,573.60
52-wk Low
Rs806.25

Chart for

About

Lupin Limited is a pharmaceutical company. The Company is engaged in producing, developing and marketing a range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) across the world. The Company offers products in the cardiovascular, diabetology, asthma, pediatrics, central... (more)

Overall

Beta: -0.05
Market Cap(Mil.): Rs469,414.59
Shares Outstanding(Mil.): 451.84
Dividend: 7.50
Yield (%): 0.72

Financials

  Industry Sector
P/E (TTM): -- 31.11 16.44
EPS (TTM): -- -- --
ROI: -- 14.85 10.61
ROE: -- 16.31 14.21

BRIEF-Lupin Announces Pan-India Launch Of Softovac

* SAYS CO FORAYS INTO OVER-THE-COUNTER SEGMENT WITH PAN-INDIA LAUNCH OF SOFTOVAC Source text - http://bit.ly/2mGumd7 Further company coverage:

15 Jan 2018

BRIEF-Lupin Gets FDA Approval For Generic Tamiflu Capsules

* LUPIN - GETS FDA APPROVAL FOR GENERIC TAMIFLU CAPSULES Source text: (http://bit.ly/2Fn4vPg) Further company coverage:

10 Jan 2018

BRIEF-Lupin Launches Generic Ancobon Capsules In U.S.

* SAYS LAUNCHES GENERIC ANCOBON CAPSULES IN U.S. Source text for Eikon: Further company coverage:

05 Jan 2018

BRIEF-Lupin Gets FDA Approval For Generic Dovonex Scalp Solution

* GETS FDA APPROVAL FOR GENERIC DOVONEX SCALP SOLUTION Source text: (http://bit.ly/2lbGh1I) Further company coverage:

28 Dec 2017

BRIEF-Lupin Gets U.S. FDA Nod For Generic Contraceptive Treatment

* SAYS LUPIN RECEIVES FDA APPROVAL FOR GENERIC SAFYRAL TABLETS

14 Dec 2017

Yes Bank, IndusInd to join India's BSE Sensex index; Lupin, Cipla dropped

Indian private sector lenders Yes Bank Ltd and IndusInd Bank Ltd will join the BSE stock exchange's 30-member Sensex index, effective Dec. 18, the index provider said on Friday.

17 Nov 2017

Yes Bank, IndusInd to join India's BSE Sensex index; Lupin, Cipla dropped

Nov 17 Indian private sector lenders Yes Bank Ltd and IndusInd Bank Ltd will join the BSE stock exchange's 30-member Sensex index, effective Dec. 18, the index provider said on Friday.

17 Nov 2017

BUZZ-India's Lupin dives to near 4-yr lows on FDA warnings

** Drugmaker Lupin Ltd plunges as much as 17.8 pct to 850 rupees, its lowest since Nov. 2013

07 Nov 2017

BRIEF-Lupin launches generic Acticlate tablets in U.S.‍​

* Says co launches generic Acticlate tablets in U.S.‍​ Source text: http://bit.ly/2ypyZzY Further company coverage:

02 Nov 2017

Lupin Q2 profit falls on lower U.S. sales, but beats estimates

Drugmaker Lupin Ltd said on Monday second-quarter net profit fell more than 30 percent, as regulatory scrutiny and pricing pressure in the United States, its biggest market, dampened sales.

30 Oct 2017

Earnings vs. Estimates